SK82098A3 - Biologically active benzothiazolone ethanamines - Google Patents

Biologically active benzothiazolone ethanamines Download PDF

Info

Publication number
SK82098A3
SK82098A3 SK820-98A SK82098A SK82098A3 SK 82098 A3 SK82098 A3 SK 82098A3 SK 82098 A SK82098 A SK 82098A SK 82098 A3 SK82098 A3 SK 82098A3
Authority
SK
Slovakia
Prior art keywords
compound
formula
pharmaceutically acceptable
compounds
acceptable salt
Prior art date
Application number
SK820-98A
Other languages
English (en)
Slovak (sk)
Inventor
Roger Bonnert
Roger Brown
Peter Cage
David Cheshire
Francis Ince
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of SK82098A3 publication Critical patent/SK82098A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SK820-98A 1995-12-23 1996-12-13 Biologically active benzothiazolone ethanamines SK82098A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526511.2A GB9526511D0 (en) 1995-12-23 1995-12-23 Pharmaceutically active compounds
PCT/SE1996/001650 WO1997023470A1 (en) 1995-12-23 1996-12-13 Biologically active benzothiazolone ethanamines

Publications (1)

Publication Number Publication Date
SK82098A3 true SK82098A3 (en) 1998-11-04

Family

ID=10786064

Family Applications (1)

Application Number Title Priority Date Filing Date
SK820-98A SK82098A3 (en) 1995-12-23 1996-12-13 Biologically active benzothiazolone ethanamines

Country Status (27)

Country Link
US (1) US5929100A (et)
EP (1) EP0918760B1 (et)
JP (1) JP2000502681A (et)
KR (1) KR19990076688A (et)
CN (1) CN1072214C (et)
AR (1) AR005008A1 (et)
AT (1) ATE209638T1 (et)
AU (1) AU704506B2 (et)
BR (1) BR9612234A (et)
CA (1) CA2238877A1 (et)
CZ (1) CZ288704B6 (et)
DE (1) DE69617472D1 (et)
EE (1) EE03440B1 (et)
GB (1) GB9526511D0 (et)
HU (1) HUP9900100A3 (et)
IL (2) IL142502A0 (et)
IS (1) IS4759A (et)
MX (1) MX9804828A (et)
NO (1) NO982927D0 (et)
NZ (1) NZ325500A (et)
PL (1) PL327475A1 (et)
RU (1) RU2177476C2 (et)
SK (1) SK82098A3 (et)
TR (1) TR199801196T2 (et)
TW (1) TW401411B (et)
WO (1) WO1997023470A1 (et)
ZA (1) ZA9610354B (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009018A1 (fr) * 1997-08-14 1999-02-25 Kirin Beer Kabushiki Kaisha DERIVES DE BENZOTHIAZOLONE PRESENTANT UNE ACTIVITE SELECTIVE D'AGONISTE DU RECEPTEUR β2
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200738659A (en) * 2005-08-29 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
DK514585A (da) * 1984-11-08 1986-05-09 Syntex Inc Aminoethylanilinderivater
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
US5648370A (en) * 1990-11-20 1997-07-15 Astra Pharmaceuticals Limited 7-(2-aminoethyl) benzothiazolones
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
CA2238877A1 (en) 1997-07-03
HUP9900100A2 (hu) 1999-05-28
GB9526511D0 (en) 1996-02-28
EE9800193A (et) 1998-12-15
CN1211242A (zh) 1999-03-17
HUP9900100A3 (en) 2001-10-29
PL327475A1 (en) 1998-12-07
NO982927L (no) 1998-06-23
AU704506B2 (en) 1999-04-22
CZ288704B6 (cs) 2001-08-15
EP0918760A1 (en) 1999-06-02
TW401411B (en) 2000-08-11
IS4759A (is) 1998-05-27
ZA9610354B (en) 1997-06-23
EE03440B1 (et) 2001-06-15
NZ325500A (en) 1999-01-28
JP2000502681A (ja) 2000-03-07
EP0918760B1 (en) 2001-11-28
IL142502A0 (en) 2002-03-10
IL124998A0 (en) 1999-01-26
BR9612234A (pt) 1999-07-13
TR199801196T2 (xx) 1998-10-21
AU1402597A (en) 1997-07-17
ATE209638T1 (de) 2001-12-15
KR19990076688A (ko) 1999-10-15
MX9804828A (es) 1998-09-30
WO1997023470A1 (en) 1997-07-03
AR005008A1 (es) 1999-04-07
NO982927D0 (no) 1998-06-23
CN1072214C (zh) 2001-10-03
CZ168498A3 (cs) 1998-09-16
US5929100A (en) 1999-07-27
RU2177476C2 (ru) 2001-12-27
DE69617472D1 (de) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2006249866B2 (en) Compositions and methods of treating retinal disease
RU2114108C1 (ru) ПРОИЗВОДНЫЕ 7-(2-АМИНОЭТИЛ)БЕНЗОТИАЗОЛОНА ИЛИ ИХ ФАРМАЦЕВТИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРОИЗВОДНЫЕ N-[2-(4-ГИДРОКСИ-2-ОКСО-3H-1,3-БЕНЗОТИАЗОЛ-7-ИЛ)ЭТИЛАМИДА]ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ПРОЯВЛЯЮЩАЯ АГОНИСТИЧЕСКУЮ АКТИВНОСТЬ В ОТНОШЕНИИ β2-АДРЕНОРЕЦЕПТОРОВ
JP4896717B2 (ja) N−メチル−置換ベンゾアミダゾール
SK82098A3 (en) Biologically active benzothiazolone ethanamines
DE69607183T2 (de) Benzothiazolone-derivate
WO1997023470A9 (en) Biologically active benzothiazolone ethanamines
AU2008333929A1 (en) Acid mimic compounds for the inhibition of isoprenyl-S-cysteinyl methyltransferase
US7399786B2 (en) Derivatives of amino acids for treatment of obesity and related disorders
EP1496053B1 (en) Kappa-opioid receptor agonist comprising a 2-phenylbenzothiazoline derivative
WO2018077898A1 (en) N,n'-diarylurea, n,n'-diarylthiourea and n,n'-diarylguanidino compounds for use in treatment and prevention of inflammatory disease
US5036086A (en) Novel benzothiazole derivatives
CN107304180B (zh) 苯甲酰胺类衍生物、其制备方法及其在医药上的用途
RU2172313C2 (ru) Соединения бензотиазолона, способы и промежуточные соединения для их получения, а также содержащие их фармацевтические композиции
JPH03148263A (ja) フェノキシプロピルアミン誘導体またはその塩ならびにこれらを含有する抗潰瘍剤